Read the latest company announcements, find out about upcoming events where you can meet Certara scientists and representatives, and sign up for upcoming webinars.
June 01, 2011
Certara™, a leading provider of software and services to improve productivity and decision-making from drug discovery through clinical development, today announced that Agios Pharmaceuticals, Inc. has selected D360 as its enterprise solution for data integration, visualization, mining and analysis, after a year-long, multi-vendor competitive process.
July 12, 2011
Certara™, a leading provider of software and services to improve productivity and decision-making from drug discovery through clinical development, today announced that a top 15 global pharmaceutical company has licensed D360 as its enterprise solution for scientific data integration and data mining, visualization, and analysis.
October 05, 2011
Certara™, a leading provider of software and services to improve productivity and decision-making from drug discovery through clinical development, announced that it will be the exclusive provider of Chemotargets software for predicting the off-target pharmacology of small molecules.
December 20, 2011
Certara™, a leading provider of software and services to improve productivity and decision-making from discovery through clinical development, announced today that it has released D360™ version 6.0, with key enhancements that enable users to access data from clinical and preclinical data sources in addition to discovery.
January 17, 2012
Certara™, a leading provider of software and services to improve productivity and decision-making from discovery through clinical development, announced today that a Top 10 pharma Company, after completing an extensive competitive review process, has selected D360 as its enterprise solution for conducting single-study and cross-study search and analysis of preclinical safety data.
February 24, 2012
Certara™, a leading provider of drug discovery and development software and scientific consulting services and a Vector portfolio company, today announced agreement to acquire Simcyp Limited.
March 13, 2012
Certara™, a Vector Capital portfolio company and a leading provider of drug discovery and development software and scientific consulting services, today announced the completion of its acquisition of UK-based Simcyp Limited.
April 10, 2012
Certara releases Phoenix version 1.3, adds new population PK/PD modeling algorithm, 64-bit support and many usability enhancements to support model-based-drug development.
From Discovery through Development
Search Our Archives
